The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma.
 
Cathy Yi Xia
No Relationships to Disclose
 
Daniel Ying Wang
No Relationships to Disclose
 
Robert Mason
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jessica Louise Smith
No Relationships to Disclose
 
Meredith Ann McKean
No Relationships to Disclose
 
Serigne Lo
No Relationships to Disclose
 
Alexander David Guminski
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Merck; Pfizer; Regeneron; Sun Pharma
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medivation/Astellas
 
Georgina V. Long
Honoraria - Bristol-Myers Squibb; Incyte; Merck; Novartis; Roche
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Incyte; MERCK; Novartis; Pierre Fabre; Roche/Genentech
 
Matteo S. Carlino
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Victoria Atkinson
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Michael Millward
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Jennifer Leigh McQuade
No Relationships to Disclose
 
Rodabe Navroze Amaria
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
 
Douglas Buckner Johnson
Consulting or Advisory Role - Array Biopharma; Bristol-Myers Squibb; Genoptix; Incyte; Merck; Novartis
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Incyte
Patents, Royalties, Other Intellectual Property - Intellectual property and patents pending surrounding use of MHC-II and response to immune therapy
 
Alexander M. Menzies
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb